Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2025 Sep 29;25(1):667.
doi: 10.1186/s12876-025-04280-5.

Comparison of pathological features of patients with antibody-negative and positive primary biliary cholangitis

Hong-Li Liu  1 , Xing Liu  2 , Yi-Fan Hu  3 , Xi-Xuan Wang  1 , Yu Zhang  3 , Li Wang  3 , Sha-Sha Li  4 , Yi-Jun Bao  3 , Si-Wei Zheng  4 , Qing-Fang Xiong  3 , Yan-Dan Zhong  3 , Du-Xian Liu  5 , Ping Huang  3 , Xiao-Ning Feng  3 , Wen-Quan Zeng  3 , Cai-Yun Zhang  2 , Kai Zhang  2 , Yong-Feng Yang  6   7
Affiliations
Comparative Study

Comparison of pathological features of patients with antibody-negative and positive primary biliary cholangitis

Hong-Li Liu et al. BMC Gastroenterol. .

Abstract

Objective: To examine the differences and similarities among primary biliary cholangitis (PBC) with positive and negative expression of autoantibodies (anti-mitochondrial antibodies AMA and AMA-M2, antinuclear antibodies anti-gp210, and anti-sp100).

Methods: Clinical and pathological data of 85 PBC in patients who underwent liver puncture biopsy were retrospectively collected from January 2016 to September 2018 at the Second Hospital of Nanjing. The differences in clinical and pathological indexes of PBC between autoantibody negative and positive groups were analyzed by SPSS 25.0, and the patients' previous autoantibody indexes were collected for follow-up.

Results: The average age of 85 PBC patients was (52.2 ± 9.2) years old, including 15 males (17.6%) and 70 females (82.4%), with a male-to-female ratio of 1:4.7. Fifty-nine autoantibody-positive cases and 26 autoantibody-negative cases were 50 (84.7%) AMA positive, 51 (86.4%) AMA-M2 positive, 21 (35.6%) anti-gp210 positive, and 15 (25.4%) anti-sp100 positive. The distribution of CK7-positive hepatocytes and the degree of bile duct injury in the portal area of PBC patients in the antibody-negative group were lower than those in the antibody-positive group (P < 0.05). There was no significant difference in the distribution of interface inflammation, plasma cell grade, ductular reaction, and fibrosis between the two groups. When the autoimmune antibodies were reexamined at 2 months-7 years (median time 1 year), AMA, AMA-M2, anti-gp210, and anti-sp100 were still negative in 16 antibody-negative patients.

Conclusions: The pathological symptoms and diagnostic patterns of autoantibody-negative and positive PBC were generally comparable. In this study, the pathological manifestations of antibody-negative PBC were similar to those of antibody-positive PBC, but the lymphocyte aggregation in antibody-negative PBC was more severe than that in antibody-positive PBC, while the degree of bile duct injury and CK7-positive hepatocytes were milder than that in antibody-positive PBC, suggesting that the overall pathological changes of antibody-negative PBC were slightly milder than those of antibody-positive PBC.

Keywords: Pathological features; Primary biliary cholangitis.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: In this retrospective study, the data are anonymous, and the requirement for informed consent was therefore waived by the Medical Ethics Committee of the Second Hospital of Nanjing. The study was approved by the examination of the Medical Ethics Committee of the Second Hospital of Nanjing, China (2020-LS-KY030). The study protocol confirmed to the ethical guidelines of the Declaration of Helsinki. Consent of publication: Not applicable. Competing interests: The authors declare no competing interests.

References

    1. You H, Duan W, Li S, Lv T, Chen S, Lu L, Ma X, Han Y, Nan Y, Xu X, Duan Z, Wei L, Jia J, Zhuang H. Chinese Society of Hepatology, Chinese Medical Association. Guidelines on the Diagnosis and Management of Primary Biliary Cholangitis (2021). J Clin Transl Hepatol. 2023;11(3):736–46.
    1. Nakanuma Y, Zen Y, Harada K, Sasaki M, Nonomura A, Uehara T, et al. Application of a new histological staging and grading system for primary biliary cirrhosis to liver biopsy specimens: interobserver agreement. Pathol Int. 2010;60(3):167–74. - DOI - PubMed
    1. Sun C, Xiao X, Yan L, Sheng L, Wang Q, Jiang P, et al. Histologically proven AMA positive primary biliary cholangitis but normal serum alkaline phosphatase: is alkaline phosphatase truly a surrogate marker? J Autoimmun. 2019;99:33–8. - DOI - PubMed
    1. Poyatos E, Morandeira F, Climent J, Mas V, Castellote J, Bas J. Detection of anti-mitochondrial 2-oxoacid dehydrogenase complex subunit's antibodies for the diagnosis of Primary Biliary Cholangitis. Clin Immunol. 2024;268:108749.
    1. Zandanell S, Strasser M, Feldman A, Strebinger G, Aigner G, Niederseer D, et al. Similar clinical outcome of AMA immunoblot-M2-negative compared to immunoblot-positive subjects over six years of follow-up. Postgrad Med. 2021;133(3):291–8. - DOI - PubMed

Publication types